v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2020     43,637,000          
Balance at beginning of period at Dec. 31, 2020 $ 619,688   $ 44 $ 873,201   $ (253,875)   $ 318
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options (in shares)     553,000          
Exercise of stock options 19,039   $ 1 19,038        
Vested restricted stock units (in shares)     302,000          
Vested restricted stock units 0              
Common stock issued under employee stock purchase plan (in shares)     31,000          
Common stock issued under employee stock purchase plan 1,574     1,574        
Stock-based compensation 31,356     31,356        
Other comprehensive loss (Note 11) (165)             (165)
Net (loss) income 47,110         47,110    
Ending balance (in shares) at Sep. 30, 2021     44,523,000          
Balance at end of period at Sep. 30, 2021 718,602   $ 45 925,169   (206,765)   153
Beginning balance (in shares) at Dec. 31, 2020     43,637,000          
Balance at beginning of period at Dec. 31, 2020 619,688   $ 44 873,201   (253,875)   318
Ending balance (in shares) at Dec. 31, 2021     44,734,000          
Balance at end of period at Dec. 31, 2021 $ 730,408 $ (49,233) $ 45 942,091 $ (96,468) (211,895) $ 47,235 167
Increase (Decrease) in Stockholders' Equity                
Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2) Accounting Standards Update 2020-06 Retrospective [Member]              
Beginning balance (in shares) at Jun. 30, 2021     44,437,000          
Balance at beginning of period at Jun. 30, 2021 $ 687,168   $ 44 911,368   (224,425)   181
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options (in shares)     74,000          
Exercise of stock options 3,018   $ 1 3,017        
Vested restricted stock units (in shares)     12,000          
Vested restricted stock units 0              
Stock-based compensation 10,784     10,784        
Other comprehensive loss (Note 11) (28)             (28)
Net (loss) income 17,660         17,660    
Ending balance (in shares) at Sep. 30, 2021     44,523,000          
Balance at end of period at Sep. 30, 2021 718,602   $ 45 925,169   (206,765)   153
Beginning balance (in shares) at Dec. 31, 2021     44,734,000          
Balance at beginning of period at Dec. 31, 2021 $ 730,408 $ (49,233) $ 45 942,091 $ (96,468) (211,895) $ 47,235 167
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options (in shares) 667,940   667,000          
Exercise of stock options $ 23,498   $ 1 23,497        
Vested restricted stock units (in shares)     324,000          
Vested restricted stock units $ 0              
Common stock issued under employee stock purchase plan (in shares) 36,729   37,000          
Common stock issued under employee stock purchase plan $ 1,821     1,821        
Stock-based compensation 35,415     35,415        
Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)     102,000          
Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) 3,040     3,040        
Other comprehensive loss (Note 11) (837)             (837)
Net (loss) income 26,011         26,011    
Ending balance (in shares) at Sep. 30, 2022     45,864,000          
Balance at end of period at Sep. 30, 2022 770,123   $ 46 909,396   (138,649)   (670)
Beginning balance (in shares) at Jun. 30, 2022     45,802,000          
Balance at beginning of period at Jun. 30, 2022 756,636   $ 46 895,151   (137,956)   (605)
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options (in shares)     37,000          
Exercise of stock options 1,563   $ 0 1,563        
Vested restricted stock units (in shares)     25,000          
Vested restricted stock units 0              
Stock-based compensation 12,682     12,682        
Other comprehensive loss (Note 11) (65)             (65)
Net (loss) income (693)         (693)    
Ending balance (in shares) at Sep. 30, 2022     45,864,000          
Balance at end of period at Sep. 30, 2022 $ 770,123   $ 46 $ 909,396   $ (138,649)   $ (670)